Clinical trials open for recruitment

The following clinical trials are in the process of recruiting participants. Some of the recruitment pathways for these trials are open to the public while others require a specialist referral. Please click on the trial links below to find out more information and register your interest.

Coeliac Disease and Immune Health - Gluten Threshold Study

A Double-Blind, Placebo-Controlled, Adaptive Dose-Response Study To Assess the Acute Effects of Gluten in Adults with Treated Coeliac Disease
Coeliac Disease and Immune Health - Dental Enamel Defects Study

Evaluating the prevalence of Coeliac Disease in children with Developmental Defects of Enamel
Coeliac Disease and Immune Health - Immunic Study

This trial is testing a potential new treatment for coeliac disease called IMU-856.
Emerald - Younger Women's Wellness After Cancer Study

A study to pilot an Australian lifestyle intervention in younger women. The intervention aims to improve health and wellness in younger women after treatment for cancer.
Neurology - Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-004 Administered Intrathecally to Patients with C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD).
Neurology - Tranexamic Acid (TXA) Dosing in Primary Total Knee Arthroplasty

A Prospective, Randomised Non-Blinded Pilot Study to Optimise Oral Tranexamic Acid Dosing in Primary Total Knee Arthroplasty
Rare Diseases - Immunoglobulin G4 (IgG4) Related Disease

A Phase 3, Randomised, Double-blind, Multicentre, Placebo-Controlled Study of Inebilizumab Efficacy and Safety in Immunoglobulin G4-related disease (IgG4) Related Disease (MITIGATE).

What do clinical trials mean to the families of participants?

Related news

Research Australia – Dr Janine Porter-Steele

Research Australia – Dr Janine Porter-Steele What is the Emerald Study and what research was utilized or implemented through this...

Coeliac Disease: This is Lou’s Story

Coeliac Disease: This is Lou’s Story When 15-year-old Lou Eborall found out she had coeliac disease nearly three years ago,...

The NITRIC Study Addresses a Known “Unknown”

The NITRIC Study Has Addressed a Known “Unknown” Statement from Dr Andreas Schibler: In Australia, approximately 12’000 children per year...

Photo Gallery: Patron Welcome Event

Last year we formed the COVID-19 Rapid Response Research Centre to support our local community, our country, and our world....

Clinical trials open for recruitment

Clinical trials open for recruitment